API Tamoxifen Citrate / Nolvadex Powder CAS 54965-24-1 For Anti Estrogen

Description:

Tamoxifen Citrate sal citratum est receptantis modulatoris antineoplastic nonsteroidalis selectivi estrogenii (SERM).Tamoxifen cancrum pectus tractare.Usus est etiam casus cancer in alto periculo aegros reducere.

Contactus: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

Whatsapp: LXXXVI CLXXXVI 2503 (LX)XLIII (WeChat & Telegram & Line)

Skype: slhyzy

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio

Specification

Product Name	Tamoxifen citrate
Nomen chemicum	(Z)-[2-[4-(1,2-diphenylbut-1-enyl)phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropaneum 1,2,3-tricarboxylatum
Alia Nomen	TAMOXIPHEN;Ethanamine 2-4-(1Z)-1,2-diphenyl-1-butenylphenoxy-N,N-dimethyl-,2-hydroxy-1,2,3-propanetricarboxylatum (1:1); TAMOXIFENCITRATEANTI-ESTROGENChemicalbook, PROTEI;TomixipheneCitrate;(Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-buteneCitrate;(Z)-2-(4-(1,2-Diphenyl-1-butenyl) phenoxy)-N,N-dimethylethanamine citrate (1:1)
CAS Number	54965-24-1
Formulae hypotheticae	C32H37NO8
Formula Pondus	563.64
Aspectus	Albus, subtilis, cristallinus
Assay	99.0% min
Liquescens punctum	140-144 °C
sarcina	pera, uter, orum, or as you required
Repono	Repone continens arcte clausus in loco sicco & frigido.Non exponere solis dirigere.
COA & MSDS	Praesto
Applicationem	Ad investigationes propositum

Testimonium Analysis / COA

Test Items	Specification	Test Proventus
Descriptio	album, bysso, crystallinum pulveris	Transi
Lepidium sativum	IR, UV conform	Transi
Solubilitas	Levissime solutum in aqua, in aceto, in chloroformi, et in alcohole, solutum in methanol.melt in 142° cum compositione.	Transi
Incassum (ex sicco ex)	≥99.0%	99.23%
Damnum in siccitate	Non plus quam 0.5%	0.26%
Reliqua ignitio	Non plus quam 0.2%	0.06%
ferrum	Non plus quam 0.05%	0.0016%
RELICTUM menstrua	Non plus quam 0.5%	Transi
Acetone	Non plus quam 0.5%	0.2%(G/G)
Metalla gravis	Non plus quam 0.001%	0.0007%
E-isonet	Non plus quam 0.3%	0.2%
conclusio	accommodat USP XXXVII "

Consuetudinem

Tamoxifen citratum etiam approbatur ne: Pectus cancer in mulieribus, quae in magno periculo sunt, pro cancro sunt.Tamoxifen citratum etiam in curatione aliarum specierum cancri studetur.